This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/DME.14496 This article is protected by copyright. All rights reserved DR THEOCHARIS KOUFAKIS (Orcid ID : 0000-0002-5853-1352) Article type : Invited Review Treating latent autoimmune diabetes in adults in the era of cardiovascular outcomes trials: Old dog should learn new tricks Theocharis Koufakis 1 , Prashanth Vas 2,3,4 , Kalliopi Kotsa 1 1 Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece 2 King’s College NHS Foundation Trust, London, United Kingdom 3 King's Health Partners' Institute of Diabetes, Endocrinology and Obesity, London, UK 4 Department of Diabetes, School of Life Course Sciences, King's College London, London, UK Correspondence: Assoc. Professor Kalliopi Kotsa, Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, 1 St. Kiriakidi Street, 54636, Thessaloniki, Greece, email: kalmanthou@yahoo.gr Word count: Abstract: 225 Text: 2794 Highlights Accepted Article